Clinical Trials Logo

Clinical Trial Summary

To determine if late (at or beyond postnatal day 14) mild permissive hypercapnia is associated with reduction in apnea, bradycardia, and hypoxemic episodes and with improved stability of oxygenation.


Clinical Trial Description

Preterm infants who remain intubated or on nasal mechanical ventilation (IMV) at 14 days postnatal age, meet blood gas criteria, have transcutaneous carbondioxide (TcCO2) monitoring with TcCO2 values that trend and correlate appropriately with PaCO2, and are not judged too unstable by Attending neonatologist will qualify. The investigators will use the data from the 96 hours of intensive multiparametric physiologic monitoring at 2 weeks postnatal age. The first 24 hours of data collection will be the baseline data. Over the next 72 hours, the investigators will evaluate 3 interventions in a cross-over manner with the initial intervention randomly assigned: Intervention 1 (24-48h of data), Intervention 2 (48-72h of data) and Intervention 3 (72-96h of data). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03333161
Study type Interventional
Source University of Alabama at Birmingham
Contact
Status Completed
Phase N/A
Start date April 9, 2018
Completion date March 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT03445689 - Oxygenation Instability and Maturation of Control of Breathing in Premature Infants
Completed NCT03245723 - Cardiac Function and Metabolism in Young Adults Born Premature (PET-MRI) N/A
Active, not recruiting NCT03575897 - Serial Assessment of Body Fat Accrual in Very Preterm Infants N/A
Completed NCT03082313 - Movement-based Infant Intervention N/A
Completed NCT03696758 - Improving Right Ventricular Function in Young Adults Born Preterm Phase 2
Withdrawn NCT01569633 - Use of Prokinetics in Early Enteral Feeding in Preterm Infants N/A
Terminated NCT03532555 - Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia N/A
Completed NCT03230032 - Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy N/A
Recruiting NCT03693287 - Personalized vs Standardized PN for Preterm Infants >1250g Phase 4
Terminated NCT03542812 - L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia Early Phase 1
Completed NCT03434743 - Non-nutritive Sucking and Breastfeeding in Preterm Infants N/A
Active, not recruiting NCT03168516 - Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants Phase 3
Completed NCT03357458 - Parent-child Interactions, Child Developmental Health, and Health System Costs at 6 Months Corrected Age N/A
Recruiting NCT03521063 - Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia. Phase 4
Recruiting NCT03501485 - Impact of Protein Supplementation to Mother Milk on Resting Energy Expenditure (REE) in Growing Healthy Preterm Infants.
Recruiting NCT06416956 - Baby-CINO: CaffeINe Treatment Optimisation in Premature Infants
Completed NCT03280381 - Nifty Feeding Cup Versus Generic Medicine Cup Preterm Infants Who Have Difficulty Breastfeeding N/A
Completed NCT03586856 - Comparison of Leakage With Nasal Prongs and Nasal Mask Interface in Newborns Receiving CPAP Treatment N/A
Completed NCT03333174 - Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 3 N/A
Active, not recruiting NCT03558737 - Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants N/A